Research Ethics

Research ethics encompasses the principles, standards, and practices that govern the responsible conduct of research, ensuring the protection of human participants, the integrity of the scientific record, and the responsible use of research resources. Core principles include respect for persons (informed consent, autonomy), beneficence (maximizing benefits and minimizing harms), justice (fair distribution of research burdens and benefits), and scientific integrity (honest reporting and avoidance of fabrication, falsification, and plagiarism).

Ethical research practices protect participants from harm, help sustain public trust in science, and maintain the integrity of the evidence base that informs clinical practice and policy. Historical abuses, including the Tuskegee syphilis study, Nazi experimentation, and the Willowbrook hepatitis studies, led to the development of foundational ethical frameworks such as the Nuremberg Code (1947), the Declaration of Helsinki (adopted by the World Medical Association in 1964 and most recently revised in October 2024), and the Belmont Report (1979), which set out the three principles of respect for persons, beneficence, and justice. Today, institutional review boards (IRBs) or research ethics committees review research involving human participants under the rules of each country; in the United States these include the Common Rule (45 CFR 46, as revised in 2018) and FDA regulations, under which some research is exempt from full review. Violations of research ethics can result in harm to participants, retraction of publications, loss of funding, and damage to individual and institutional reputations.

Research ethics operates at multiple levels. At the institutional level, IRBs or research ethics committees review study protocols before data collection begins, assessing the risks and benefits to participants, the adequacy of informed consent procedures, the protection of vulnerable populations, and the scientific merit of the proposed research. Approval is required before enrollment of participants can begin, and ongoing oversight, such as approval of amendments and continuing review where required, is meant to keep the study compliant.

At the individual level, researchers are responsible for obtaining voluntary informed consent from participants (or their legally authorized representatives), unless an ethics committee has approved a waiver, ensuring that consent is based on a clear understanding of the study's purpose, procedures, risks, benefits, alternatives, and the right to withdraw at any time. Special protections apply to vulnerable populations, including children, prisoners, pregnant women, and individuals with cognitive impairments.

Data integrity and responsible conduct require honest reporting of methods and results, proper attribution of others' work, transparent disclosure of conflicts of interest, responsible data management and storage, and compliance with data sharing policies. Fabrication (inventing data), falsification (manipulating data or results), and plagiarism (claiming others' work as one's own) are the most serious violations of research integrity (in the United States they make up the federal definition of research misconduct, used in the Public Health Service regulation 42 CFR Part 93) and can result in retraction, institutional sanctions, and debarment from funding.

Ethical considerations extend to animal research (guided by the 3Rs framework, built into animal welfare law in places such as the European Union: replacement, reduction, and refinement), environmental impact, dual use research of concern (research that could be misused for harmful purposes), and the equitable inclusion of diverse populations in research to ensure that the benefits of research extend to all communities.

Apply research ethics principles at every stage of the research process: design, participant recruitment, data collection, analysis, reporting, and dissemination. Obtain IRB or ethics committee approval, or a formal determination that the study is exempt or is not human subjects research, before beginning research involving human participants or their identifiable data. Maintain ethical standards throughout the study, not just during the approval process. When conducting secondary analysis of existing data, verify that the original consent and ethical approvals cover the proposed use.

A common error is treating IRB approval as a one time event rather than an ongoing obligation, failing to submit amendments when the protocol changes or report adverse events. Another mistake is obtaining consent that meets legal requirements but fails to ensure genuine understanding, particularly with participants who have limited literacy, language barriers, or cognitive impairments. Researchers sometimes neglect to consider the ethical implications of data sharing and storage, particularly with identifiable data. Finally, authorship disputes and inappropriate authorship (including guest and ghost authorship) are common but underrecognized ethical violations.

A multinational clinical trial of a new tuberculosis vaccine plans to enroll participants in low resource settings where tuberculosis is endemic. The research ethics committee requires that the informed consent process be conducted in the local language with culturally appropriate materials, that the control arm receive the best proven intervention unless the Declaration of Helsinki's narrow conditions for using a placebo are met, and that post trial provisions be arranged before the trial begins for participants who would still benefit from the vaccine if it proves beneficial and reasonably safe, with a plan agreed with local health authorities for wider access. The committee also requires a data safety monitoring board to review interim analyses and the establishment of a community advisory board to ensure ongoing engagement.